Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Perfect counterfactuals for epidemic simulations.

Kaminsky J, Keegan LT, Metcalf CJE, Lessler J.

Philos Trans R Soc Lond B Biol Sci. 2019 Jul 8;374(1776):20180279. doi: 10.1098/rstb.2018.0279.

PMID:
31104612
2.

Risk Factors for Household Vector Abundance Using Indoor CDC Light Traps in a High Malaria Transmission Area of Northern Zambia.

Hast MA, Stevenson JC, Muleba M, Chaponda M, Kabuya JB, Mulenga M, Lessler J, Shields T, Moss WJ, Norris DE, For The Southern And Central Africa International Centers Of Excellence In Malaria Research.

Am J Trop Med Hyg. 2019 May 6. doi: 10.4269/ajtmh.18-0875. [Epub ahead of print]

PMID:
31074411
3.

Measles and the canonical path to elimination.

Graham M, Winter AK, Ferrari M, Grenfell B, Moss WJ, Azman AS, Metcalf CJE, Lessler J.

Science. 2019 May 10;364(6440):584-587. doi: 10.1126/science.aau6299.

PMID:
31073065
4.

The impact of three years of targeted IRS with pirimiphos-methyl on malaria parasite prevalence in a high-transmission area of northern Zambia.

Hast MA, Chaponda M, Muleba M, Kabuya JB, Lupiya J, Kobayashi T, Shields T, Lessler J, Mulenga M, Stevenson JC, Norris DE, Moss WJ.

Am J Epidemiol. 2019 May 7. pii: kwz107. doi: 10.1093/aje/kwz107. [Epub ahead of print]

PMID:
31062839
5.

Mapping vaccination coverage to explore the effects of delivery mechanisms and inform vaccination strategies.

Utazi CE, Thorley J, Alegana VA, Ferrari MJ, Takahashi S, Metcalf CJE, Lessler J, Cutts FT, Tatem AJ.

Nat Commun. 2019 Apr 9;10(1):1633. doi: 10.1038/s41467-019-09611-1.

6.

A methodological comparison of risk scores versus decision trees for predicting drug-resistant infections: A case study using extended-spectrum beta-lactamase (ESBL) bacteremia.

Goodman KE, Lessler J, Harris AD, Milstone AM, Tamma PD.

Infect Control Hosp Epidemiol. 2019 Apr;40(4):400-407. doi: 10.1017/ice.2019.17. Epub 2019 Mar 4.

PMID:
30827286
7.

Estimating cholera incidence with cross-sectional serology.

Azman AS, Lessler J, Luquero FJ, Bhuiyan TR, Khan AI, Chowdhury F, Kabir A, Gurwith M, Weil AA, Harris JB, Calderwood SB, Ryan ET, Qadri F, Leung DT.

Sci Transl Med. 2019 Feb 20;11(480). pii: eaau6242. doi: 10.1126/scitranslmed.aau6242.

8.

Differential mobility and local variation in infection attack rate.

Haw DJ, Cummings DAT, Lessler J, Salje H, Read JM, Riley S.

PLoS Comput Biol. 2019 Jan 22;15(1):e1006600. doi: 10.1371/journal.pcbi.1006600. eCollection 2019 Jan.

9.
10.

Characterizing the impact of spatial clustering of susceptibility for measles elimination.

Truelove SA, Graham M, Moss WJ, Metcalf CJE, Ferrari MJ, Lessler J.

Vaccine. 2019 Jan 29;37(5):732-741. doi: 10.1016/j.vaccine.2018.12.012. Epub 2018 Dec 19.

11.

The 1918 Influenza Pandemic: Looking Back, Looking Forward.

Viboud C, Lessler J.

Am J Epidemiol. 2018 Dec 1;187(12):2493-2497. doi: 10.1093/aje/kwy207.

PMID:
30346477
12.

The Epidemiology of Cholera in Zanzibar: Implications for the Zanzibar Comprehensive Cholera Elimination Plan.

Bi Q, Abdalla FM, Masauni S, Reyburn R, Msambazi M, Deglise C, von Seidlein L, Deen J, Jiddawi MS, Olson D, Nemes I, Taib JA, Lessler J, Andemichael GR, Azman AS.

J Infect Dis. 2018 Oct 15;218(suppl_3):S173-S180. doi: 10.1093/infdis/jiy500.

13.

A spatial regression model for the disaggregation of areal unit based data to high-resolution grids with application to vaccination coverage mapping.

Utazi CE, Thorley J, Alegana VA, Ferrari MJ, Nilsen K, Takahashi S, Metcalf C, Lessler J, Tatem AJ.

Stat Methods Med Res. 2018 Sep 19:962280218797362. doi: 10.1177/0962280218797362. [Epub ahead of print]

PMID:
30229698
14.

Contact tracing performance during the Ebola epidemic in Liberia, 2014-2015.

Swanson KC, Altare C, Wesseh CS, Nyenswah T, Ahmed T, Eyal N, Hamblion EL, Lessler J, Peters DH, Altmann M.

PLoS Negl Trop Dis. 2018 Sep 12;12(9):e0006762. doi: 10.1371/journal.pntd.0006762. eCollection 2018 Sep.

15.

Timescales of influenza A/H3N2 antibody dynamics.

Kucharski AJ, Lessler J, Cummings DAT, Riley S.

PLoS Biol. 2018 Aug 20;16(8):e2004974. doi: 10.1371/journal.pbio.2004974. eCollection 2018 Aug.

16.

Oral cholera vaccine in cholera prevention and control, Malawi.

M'bangombe M, Pezzoli L, Reeder B, Kabuluzi S, Msyamboza K, Masuku H, Ngwira B, Cavailler P, Grandesso F, Palomares A, Beck N, Shaffer A, MacDonald E, Senbete M, Lessler J, Moore SM, Azman AS.

Bull World Health Organ. 2018 Jun 1;96(6):428-435. doi: 10.2471/BLT.17.207175. Epub 2018 Apr 23.

17.

Revealing Measles Outbreak Risk With a Nested Immunoglobulin G Serosurvey in Madagascar.

Winter AK, Wesolowski AP, Mensah KJ, Ramamonjiharisoa MB, Randriamanantena AH, Razafindratsimandresy R, Cauchemez S, Lessler J, Ferrari MJ, Metcalf CJE, Héraud JM.

Am J Epidemiol. 2018 Oct 1;187(10):2219-2226. doi: 10.1093/aje/kwy114.

18.

Reconstruction of antibody dynamics and infection histories to evaluate dengue risk.

Salje H, Cummings DAT, Rodriguez-Barraquer I, Katzelnick LC, Lessler J, Klungthong C, Thaisomboonsuk B, Nisalak A, Weg A, Ellison D, Macareo L, Yoon IK, Jarman R, Thomas S, Rothman AL, Endy T, Cauchemez S.

Nature. 2018 May;557(7707):719-723. doi: 10.1038/s41586-018-0157-4. Epub 2018 May 23.

19.

Micro-Hotspots of Risk in Urban Cholera Epidemics.

Azman AS, Luquero FJ, Salje H, Mbaïbardoum NN, Adalbert N, Ali M, Bertuzzo E, Finger F, Toure B, Massing LA, Ramazani R, Saga B, Allan M, Olson D, Leglise J, Porten K, Lessler J.

J Infect Dis. 2018 Aug 24;218(7):1164-1168. doi: 10.1093/infdis/jiy283.

20.

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination.

Winter AK, Martinez ME, Cutts FT, Moss WJ, Ferrari MJ, McKee A, Lessler J, Hayford K, Wallinga J, Metcalf CJE.

J Infect Dis. 2018 Jul 2;218(3):355-364. doi: 10.1093/infdis/jiy137. Erratum in: J Infect Dis. 2018 Aug 14;218(6):1014.

21.

Challenges and Opportunities in Disease Forecasting in Outbreak Settings: A Case Study of Measles in Lola Prefecture, Guinea.

Graham M, Suk JE, Takahashi S, Metcalf CJ, Jimenez AP, Prikazsky V, Ferrari MJ, Lessler J.

Am J Trop Med Hyg. 2018 May;98(5):1489-1497. doi: 10.4269/ajtmh.17-0218. Epub 2018 Mar 8.

22.

Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales.

Lessler J, Moore SM, Luquero FJ, McKay HS, Grais R, Henkens M, Mengel M, Dunoyer J, M'bangombe M, Lee EC, Djingarey MH, Sudre B, Bompangue D, Fraser RSM, Abubakar A, Perea W, Legros D, Azman AS.

Lancet. 2018 May 12;391(10133):1908-1915. doi: 10.1016/S0140-6736(17)33050-7. Epub 2018 Mar 1.

23.

The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study.

Finger F, Bertuzzo E, Luquero FJ, Naibei N, Touré B, Allan M, Porten K, Lessler J, Rinaldo A, Azman AS.

PLoS Med. 2018 Feb 27;15(2):e1002509. doi: 10.1371/journal.pmed.1002509. eCollection 2018 Feb.

24.

Prospective forecasts of annual dengue hemorrhagic fever incidence in Thailand, 2010-2014.

Lauer SA, Sakrejda K, Ray EL, Keegan LT, Bi Q, Suangtho P, Hinjoy S, Iamsirithaworn S, Suthachana S, Laosiritaworn Y, Cummings DAT, Lessler J, Reich NG.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2175-E2182. doi: 10.1073/pnas.1714457115. Epub 2018 Feb 20.

25.

High resolution age-structured mapping of childhood vaccination coverage in low and middle income countries.

Utazi CE, Thorley J, Alegana VA, Ferrari MJ, Takahashi S, Metcalf CJE, Lessler J, Tatem AJ.

Vaccine. 2018 Mar 14;36(12):1583-1591. doi: 10.1016/j.vaccine.2018.02.020. Epub 2018 Feb 14.

26.

Quantifying the Risk and Cost of Active Monitoring for Infectious Diseases.

Reich NG, Lessler J, Varma JK, Vora NM.

Sci Rep. 2018 Jan 18;8(1):1093. doi: 10.1038/s41598-018-19406-x.

27.

Simulations for designing and interpreting intervention trials in infectious diseases.

Halloran ME, Auranen K, Baird S, Basta NE, Bellan SE, Brookmeyer R, Cooper BS, DeGruttola V, Hughes JP, Lessler J, Lofgren ET, Longini IM, Onnela JP, Özler B, Seage GR, Smith TA, Vespignani A, Vynnycky E, Lipsitch M.

BMC Med. 2017 Dec 29;15(1):223. doi: 10.1186/s12916-017-0985-3.

28.

Quantifying Zika: Advancing the Epidemiology of Zika With Quantitative Models.

Keegan LT, Lessler J, Johansson MA.

J Infect Dis. 2017 Dec 16;216(suppl_10):S884-S890. doi: 10.1093/infdis/jix437. Review.

29.

Rubella vaccination in India: identifying broad consequences of vaccine introduction and key knowledge gaps.

Winter AK, Pramanik S, Lessler J, Ferrari M, Grenfell BT, Metcalf CJE.

Epidemiol Infect. 2018 Jan;146(1):65-77. doi: 10.1017/S0950268817002527. Epub 2017 Dec 4.

30.

HIV Prevention Efforts and Incidence of HIV in Uganda.

Grabowski MK, Serwadda DM, Gray RH, Nakigozi G, Kigozi G, Kagaayi J, Ssekubugu R, Nalugoda F, Lessler J, Lutalo T, Galiwango RM, Makumbi F, Kong X, Kabatesi D, Alamo ST, Wiersma S, Sewankambo NK, Tobian AAR, Laeyendecker O, Quinn TC, Reynolds SJ, Wawer MJ, Chang LW; Rakai Health Sciences Program.

N Engl J Med. 2017 Nov 30;377(22):2154-2166. doi: 10.1056/NEJMoa1702150.

31.

Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis.

Bi Q, Ferreras E, Pezzoli L, Legros D, Ivers LC, Date K, Qadri F, Digilio L, Sack DA, Ali M, Lessler J, Luquero FJ, Azman AS; Oral Cholera Vaccine Working Group of The Global Task Force on Cholera Control.

Lancet Infect Dis. 2017 Oct;17(10):1080-1088. doi: 10.1016/S1473-3099(17)30359-6. Epub 2017 Jul 17. Review.

32.

What is a Hotspot Anyway?

Lessler J, Azman AS, McKay HS, Moore SM.

Am J Trop Med Hyg. 2017 Jun;96(6):1270-1273. doi: 10.4269/ajtmh.16-0427.

33.

High Hepatitis E Seroprevalence Among Displaced Persons in South Sudan.

Azman AS, Bouhenia M, Iyer AS, Rumunu J, Laku RL, Wamala JF, Rodriguez-Barraquer I, Lessler J, Gignoux E, Luquero FJ, Leung DT, Gurley ES, Ciglenecki I.

Am J Trop Med Hyg. 2017 Jun;96(6):1296-1301. doi: 10.4269/ajtmh.16-0620.

34.

Opportunities and challenges in modeling emerging infectious diseases.

Metcalf CJE, Lessler J.

Science. 2017 Jul 14;357(6347):149-152. doi: 10.1126/science.aam8335. Review.

PMID:
28706037
35.

Bacterial Infections in Neonates Following Mupirocin-Based MRSA Decolonization: A Multicenter Cohort Study.

Pierce R, Bryant K, Elward A, Lessler J, Milstone AM.

Infect Control Hosp Epidemiol. 2017 Aug;38(8):930-936. doi: 10.1017/ice.2017.108. Epub 2017 Jun 5.

36.

The geography of measles vaccination in the African Great Lakes region.

Takahashi S, Metcalf CJE, Ferrari MJ, Tatem AJ, Lessler J.

Nat Commun. 2017 May 25;8:15585. doi: 10.1038/ncomms15585.

37.

El Niño and the shifting geography of cholera in Africa.

Moore SM, Azman AS, Zaitchik BF, Mintz ED, Brunkard J, Legros D, Hill A, McKay H, Luquero FJ, Olson D, Lessler J.

Proc Natl Acad Sci U S A. 2017 Apr 25;114(17):4436-4441. doi: 10.1073/pnas.1617218114. Epub 2017 Apr 10.

38.

Dengue diversity across spatial and temporal scales: Local structure and the effect of host population size.

Salje H, Lessler J, Maljkovic Berry I, Melendrez MC, Endy T, Kalayanarooj S, A-Nuegoonpipat A, Chanama S, Sangkijporn S, Klungthong C, Thaisomboonsuk B, Nisalak A, Gibbons RV, Iamsirithaworn S, Macareo LR, Yoon IK, Sangarsang A, Jarman RG, Cummings DA.

Science. 2017 Mar 24;355(6331):1302-1306. doi: 10.1126/science.aaj9384.

39.

Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?

Prada JM, Metcalf CJE, Takahashi S, Lessler J, Tatem AJ, Ferrari M.

Vaccine. 2017 Mar 13;35(11):1488-1493. doi: 10.1016/j.vaccine.2017.02.008. Epub 2017 Feb 16.

40.

Impact of interventions and the incidence of ebola virus disease in Liberia-implications for future epidemics.

Kirsch TD, Moseson H, Massaquoi M, Nyenswah TG, Goodermote R, Rodriguez-Barraquer I, Lessler J, Cumings DA, Peters DH.

Health Policy Plan. 2017 Mar 1;32(2):205-214. doi: 10.1093/heapol/czw113. Erratum in: Health Policy Plan. 2017 May 1;32(4):602.

41.

Case study in evaluating time series prediction models using the relative mean absolute error.

Reich NG, Lessler J, Sakrejda K, Lauer SA, Iamsirithaworn S, Cummings DA.

Am Stat. 2016;70(3):285-292. doi: 10.1080/00031305.2016.1148631. Epub 2016 Aug 10.

42.

Phylogenetic insights into age-disparate partnerships and HIV.

Grabowski MK, Lessler J.

Lancet HIV. 2017 Jan;4(1):e8-e9. doi: 10.1016/S2352-3018(16)30184-9. Epub 2016 Dec 1. No abstract available.

PMID:
27914876
43.

Meticillin-resistant Staphylococcus aureus (MRSA) acquisition risk in an endemic neonatal intensive care unit with an active surveillance culture and decolonization programme.

Pierce R, Lessler J, Popoola VO, Milstone AM.

J Hosp Infect. 2017 Jan;95(1):91-97. doi: 10.1016/j.jhin.2016.10.022. Epub 2016 Nov 4.

44.

Times to key events in Zika virus infection and implications for blood donation: a systematic review.

Lessler J, Ott CT, Carcelen AC, Konikoff JM, Williamson J, Bi Q, Kucirka LM, Cummings DA, Reich NG, Chaisson LH.

Bull World Health Organ. 2016 Nov 1;94(11):841-849. Review.

45.

How social structures, space, and behaviors shape the spread of infectious diseases using chikungunya as a case study.

Salje H, Lessler J, Paul KK, Azman AS, Rahman MW, Rahman M, Cummings D, Gurley ES, Cauchemez S.

Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13420-13425. Epub 2016 Nov 7.

46.

Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan.

Iyer AS, Bouhenia M, Rumunu J, Abubakar A, Gruninger RJ, Pita J, Lino RL, Deng LL, Wamala JF, Ryan ET, Martin S, Legros D, Lessler J, Sack DA, Luquero FJ, Leung DT, Azman AS.

Sci Rep. 2016 Oct 24;6:35742. doi: 10.1038/srep35742.

47.

Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study.

Azman AS, Parker LA, Rumunu J, Tadesse F, Grandesso F, Deng LL, Lino RL, Bior BK, Lasuba M, Page AL, Ontweka L, Llosa AE, Cohuet S, Pezzoli L, Sodjinou DV, Abubakar A, Debes AK, Mpairwe AM, Wamala JF, Jamet C, Lessler J, Sack DA, Quilici ML, Ciglenecki I, Luquero FJ.

Lancet Glob Health. 2016 Nov;4(11):e856-e863. doi: 10.1016/S2214-109X(16)30211-X.

48.

Estimating infectious disease transmission distances using the overall distribution of cases.

Salje H, Cummings DAT, Lessler J.

Epidemics. 2016 Dec;17:10-18. doi: 10.1016/j.epidem.2016.10.001. Epub 2016 Oct 7.

49.

Impact on Epidemic Measles of Vaccination Campaigns Triggered by Disease Outbreaks or Serosurveys: A Modeling Study.

Lessler J, Metcalf CJ, Cutts FT, Grenfell BT.

PLoS Med. 2016 Oct 11;13(10):e1002144. doi: 10.1371/journal.pmed.1002144. eCollection 2016 Oct.

50.

Heterogeneity of the HIV epidemic in agrarian, trading, and fishing communities in Rakai, Uganda: an observational epidemiological study.

Chang LW, Grabowski MK, Ssekubugu R, Nalugoda F, Kigozi G, Nantume B, Lessler J, Moore SM, Quinn TC, Reynolds SJ, Gray RH, Serwadda D, Wawer MJ.

Lancet HIV. 2016 Aug;3(8):e388-e396. doi: 10.1016/S2352-3018(16)30034-0. Epub 2016 Jul 9.

Supplemental Content

Loading ...
Support Center